Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Misclassification of UDCA treatment response in patients with primary biliary cholangitis (PBC) in the real-world setting.

Annals of hepatology·2026
Same author

Analysis of B-Scan Ultrasonography Using Neural Networks to Predict Risk of Fibrosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Ultrasound in medicine & biology·2026
Same author

Growth Differentiation Factor 15 (GDF-15) as a modulator of hepatic steatosis and fibrosis: insights from a 6-year retrospective cohort study.

Frontiers in medicine·2026
Same author

Sex-based differences in hepatitis delta virus infection: Insights from the Italian PITER hepatitis delta virus cohort.

World journal of gastroenterology·2026
Same author

Clinical characteristics of newly diagnosed patients with primary biliary cholangitis (PBC) indicate the need for better awareness on timely diagnosis and adequate UDCA therapy.

Zeitschrift fur Gastroenterologie·2025
Same author

Impact of Handling Perception and Language Barriers on Virologic Response to Daily Subcutaneous Bulevirtide in Hepatitis D.

Liver international : official journal of the International Association for the Study of the Liver·2025

Related Experiment Video

Updated: Jul 2, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Acute hepatitis C: current status and remaining challenges.

Teresa Santantonio1, Johannes Wiegand, J Tilman Gerlach

  • 1Clinic of Infectious Diseases, University of Bari, Policlinico, Bari, Italy. t.santantonio@clininf.uniba.it

Journal of Hepatology
|August 19, 2008
PubMed
Summary

Acute hepatitis C virus (HCV) infection is often asymptomatic, making diagnosis difficult. This review covers HCV epidemiology, risk factors, and current treatment challenges, highlighting the need for standardized management guidelines.

More Related Videos

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Related Experiment Videos

Last Updated: Jul 2, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Virology

Background:

  • Acute hepatitis C virus (HCV) infection is a critical stage with variable outcomes, progressing to spontaneous resolution or chronic disease.
  • Diagnosis is challenging due to frequent asymptomatic presentation, complicating early intervention.
  • Lack of established treatment guidelines forces clinicians to make difficult therapeutic decisions regarding treatment initiation and regimen selection.

Purpose of the Study:

  • To review the epidemiology, risk factors, and transmission routes of acute HCV infection.
  • To examine current treatment practices for acute hepatitis C.
  • To identify unresolved issues and the need for further research to establish standardized treatment guidelines.

Main Methods:

  • Review of published clinical studies and epidemiological data on acute hepatitis C.
  • Analysis of current treatment approaches, including pegylated interferon alfa monotherapy.
  • Discussion of unresolved clinical questions and areas requiring further investigation.

Main Results:

  • Acute hepatitis C is often asymptomatic, hindering timely diagnosis and treatment.
  • Pegylated interferon alfa monotherapy is the most common treatment, but the role of ribavirin is not yet defined.
  • Significant challenges exist in managing acute HCV due to a lack of standardized guidelines.

Conclusions:

  • Standardized treatment guidelines are urgently needed for the effective management of acute hepatitis C.
  • Further clinical studies are essential to address current uncertainties in treatment strategies.
  • Improved diagnostic approaches may facilitate earlier detection and intervention for acute HCV infection.